Skip to main content

Baugh & Associates, LLC

SEC CIK
0001730818
Latest filing
Jul 10, 2026

ABBV holding history

AbbVie Inc. in every 13F filed by Baugh & Associates, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings

Shares (Q2 2026)
37,494
Value
$9.43M
% of portfolio
4.2%
Quarters held
22
Since Q1 2021
Holdings of ABBV by Baugh & Associates, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202637,494$9.43M4.2%−2,831−7.0%ReducedHolders
Q1 202640,325$8.77M3.8%−186−0.5%ReducedHolders
Q4 202540,511$8.65M4.3%−1,251−3.0%ReducedHolders
Q3 202541,762$8.91M4.4%−981−2.3%ReducedHolders
Q2 202542,743$7.35M3.8%−2,214−4.9%ReducedHolders
Q1 202544,957$9.06M4.6%−219−0.5%ReducedHolders
Q4 202445,176$7.77M4.0%+816+1.8%AddedHolders
Q3 202444,360$8.53M4.4%+390+0.9%AddedHolders
Q2 202443,970$7.90M4.1%−2,236−4.8%ReducedHolders
Q1 202446,206$8.41M4.5%−33−0.1%ReducedHolders
Q4 202346,239$7.17M4.1%−636−1.4%ReducedHolders
Q3 202346,875$6.99M4.4%−136−0.3%ReducedHolders
Q2 202347,011$6.33M3.8%+685+1.5%AddedHolders
Q1 202346,326$7.51M4.8%−966−2.0%ReducedHolders
Q4 202247,292$7.64M5.0%−120.0%ReducedHolders
Q3 202247,304$6.35M4.5%−170.0%ReducedHolders
Q2 202247,321$7.25M4.9%−525−1.1%ReducedHolders
Q1 202247,846$7.76M4.6%−230−0.5%ReducedHolders
Q4 202148,076$6.51M3.6%+369+0.8%AddedHolders
Q3 202147,707$5.15M3.2%−40.0%ReducedHolders
Q2 202147,711$5.37M3.3%−576−1.2%ReducedHolders
Q1 202148,287$5.23M3.5%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.